(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Markers of inflammation increase with tau but not amyloid in Alzheimer's disease.

What is it about?

Inflammation is seen as a driver for Alzheimer's Disease. In this study we identified that novel markers of inflammation, such as Adenosine Deaminase, which is responsible for sleep regulation, are predictive of the likelihood of Alzheimer's in a clinical population.

Why is it important?

Our study found increased levels of specific markers of inflammation in Alzheimer's Disease. These markers may in future help identify which patients are at most risk of progression to Alzheimer's. Further validation is required to assess the prognostic efficacy of these inflammation markers when used in conjunction with established measures of Alzheimer's Disease.

Read more on Kudos…
The following have contributed to this page:
sofia michopoulou
' ,"url"));